17 03, 2016

DECAF score predicts acute COPD exacerbation mortality

2019-06-18T23:43:42+00:00

DECAF score predicts acute COPD exacerbation mortality Preventing COPD exacerbations has become an important goal in clinical management and a primary outcome in many COPD research trials. This is understandable - not only is the worsening of COPD distressing for patients but exacerbations can be severe enough to result in hospitalization and death. [...]

DECAF score predicts acute COPD exacerbation mortality2019-06-18T23:43:42+00:00
16 03, 2016

COPD Symposium Online!

2019-06-18T23:48:07+00:00

COPD Symposium Online! I’ve been slow to catch up to this development even though I’ve been a part of it. Each year, the European Respiratory Society holds its annual scientific meeting to share late-breaking news in the field of respiratory medicine. It’s a sprawling meeting hosting more than 20,000 international attendees who may [...]

COPD Symposium Online!2019-06-18T23:48:07+00:00
14 05, 2014

Inspiration Research Contributes to Groundbreaking Study

2019-06-18T23:57:42+00:00

Inspiration Research Contributes to Groundbreaking Study KAMADA Pharmaceutical ("Kamada") conducted a Phase II/III clinical trial on the efficacy of proprietary inhaled Alpha-­1 Antitrypsin (AAT) therapy for the treatment of Alpha-­1 Antitrypsin Deficiency (AATD or inherited emphysema) which involved a multi-centre, randomized, double-blind, placebo-controlled study designed to evaluate Kamada's formulation of human AAT to [...]

Inspiration Research Contributes to Groundbreaking Study2019-06-18T23:57:42+00:00